Pregled bibliografske jedinice broj: 266834
Deep venous thrombosis-a clinical epidemiology overview
Deep venous thrombosis-a clinical epidemiology overview // Neurologia Croatica 2006 ; 55 (suppl 3) / Gašparović, Vladimir ; Radonić, Radovan (ur.).
Zagreb: Hrvatski lječnički zbor: Hrvatsko društvo za intenzivnu medicinu, 2006. str. 178-178 (poster, domaća recenzija, sažetak, stručni)
CROSBI ID: 266834 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Deep venous thrombosis-a clinical epidemiology overview
Autori
Alfirević, Zrinka ; Vučičević, Željko ; Sobočan, Nikola ; Sharma, Mirella ; Degoricija, Vesna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Neurologia Croatica 2006 ; 55 (suppl 3)
/ Gašparović, Vladimir ; Radonić, Radovan - Zagreb : Hrvatski lječnički zbor: Hrvatsko društvo za intenzivnu medicinu, 2006, 178-178
Skup
3rd Central European Congress on Intensive Care Medicine
Mjesto i datum
Brijuni, Hrvatska, 26.06.2006. - 29.06.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
deep venous thrombosis-therapy; epidemiology; outcome
Sažetak
Aim. To determine clinical findings, risk factors of deep venous thrombosis (DVT) and outcomes in our group of patients. Methods. A retrospective review of 203 patients treated for DVT at the intensive care unit of the Sestre milosrdnice University hospital in Zagreb over 8-year period. Eighty-five (41.9%) were male and 118 (58.1%) were female, mean age 58. Epidemiological analysis was performed according to sex, age, previous DVT, outcomes and risk factors (obesity, cancer, recent surgery and immobilisation, acquired or familial thrombophilia). Results. Seven (2.3%) patients died, six of pulmonary embolism and one of acute myocardial infarction. Personal history was negative in 171 (84%). Obesity was present in 54 (26.6%), bed rest in 48 (23.6%), estrogen consumption in 16 (7.9%) patients, malignant neoplastic disease in 38 (18.7%) patients, the most frequent was brest cancer (3.4%) in the group of middle aged women. Factors of thrombophilia have been performed in 19 patients. Of these three factors observed together the most frequent were MTHRF+PAI-1 heterozygous alterations in 5 (26.3%) patients and FV heterozygous alterations in 3 (15.8%) patients. Conclusion. Individual risk stratification is needed in order to modify exposures, and target primary and secondary prophylaxis to the person who would benefit most.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Vesna Degoricija
(autor)